Skip to main content

Table 1 Clinical characteristics and first-line treatment modalities

From: Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

 

No. of patients (%)

n = 75 (100)

Median age [range], years

54 [16–83]

Sex

 Men

 Women

51 (68)

24 (32)

Ann Arbor stage

 IE-IIE

 IIIE-IVE

 B symptoms

34 (45)

41 (55)

26 (35)

LDH

 Elevated

 Normal

 Missing

41 (56)

32 (44)

2

ECOG

 0–1

  > 1

 Missing

50 (72)

19 (28)

6

No. of extranodal sites

 1

 2

 3

  > 3

24 (32)

30 (40)

13 (17)

8 (11)

Calcium

 Elevated

 Normal

 Missing

6 (9)

62 (91)

7

AP

 Elevated

 Normal

 Missing

14 (22)

50 (78)

11

Skeletal involvement

 Unifocal

 Multifocal

45 (60)

30 (40)

Chemotherapy

 Palliative

 CHOP

 more intensive than CHOP

2 (3)

46 (61)

27 (36)

Rituximab

60 (80)

Radiotherapy

37 (49)

CNS treatment

20 (27)

Autologous transplantation

6 (8)